BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BIOTECanada - ECPv6.6.4.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BIOTECanada
X-ORIGINAL-URL:https://www.biotech.ca
X-WR-CALDESC:Events for BIOTECanada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251103
DTEND;VALUE=DATE:20251106
DTSTAMP:20260624T081934
CREATED:20250121T155120Z
LAST-MODIFIED:20251002T111523Z
UID:10000447-1762128000-1762387199@www.biotech.ca
SUMMARY:Bio Europe
DESCRIPTION:BIO-Europe returns next year on November 3-5\, 2025 in beautiful Vienna. \nGet ready to connect with top biotech innovators\, investors\, and industry leaders from around the world. Mark your calendars and stay tuned for updates on registration and event highlights! \nBIOTECanada is proud to once again support Team Canada at BIO-Europe in Vienna this November. \nAs Europe’s largest biopharma partnering conference\, BIO-Europe connects biotech and pharma leaders through high-impact meetings\, expert sessions\, and strategic networking\, making it a key platform for advancing Canada’s biotech presence on the world stage. \nAre you attending BIO-Europe in Vienna? Let us know\, we’re here to help spotlight your company and share your story as part of Team Canada. \nBIOTECanada members receive 15% off the registration fee. \nObtain your VIP discount code here 
URL:https://www.biotech.ca/event/bio-europe-2025/
CATEGORIES:Discounted for BIOTECanada Members
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251104T110000
DTEND;TZID=America/Toronto:20251104T120000
DTSTAMP:20260624T081934
CREATED:20251015T141331Z
LAST-MODIFIED:20251015T141440Z
UID:10000493-1762254000-1762257600@www.biotech.ca
SUMMARY:STECELL Technologies - In Vivo panCAR™ Therapy Using Circular RNA for the Treatment of Autoimmune Disease
DESCRIPTION:Recently\, traditional ex vivo-generated chimeric antigen receptor T (CAR-T) cell therapies have shown success in the clinic for autoimmune diseases. However\, these treatments can be limited by manufacturing\, safety\, and accessibility challenges. The prospect of an in vivo CAR-T cell therapy\, without the need for patient cell isolation\, cell culturing\, and the safety risks associated with preconditioning regimens\, remains a therapeutic goal. \nOrna Therapeutics is a biotechnology company focused on the development of engineered circular RNA (oRNA®) and proprietary immunotropic lipid nanoparticles (LNPs). These components make up Orna’s innovative panCAR™ platform that drives CAR expression on the surface of immune effector cells after in vivo administration. In this webinar\, we provide a detailed overview of this non-viral platform that results in the safe and efficient in vivo reprogramming of immune cells. We share the advantages of this technology\, such as simplified production\, higher protein expression\, and better stability. The webinar will also include preclinical data demonstrating the utility of Orna’s anti-CD19 panCAR™ as a promising\, non-viral\, scalable\, and tunable therapy with the potential to transform treatment of autoimmune diseases. \n\n\nPresenters\n\n\n\n\n\nTommy Lee\, PhD\nAssociate Director\nDiscovery Biology\nOrna Therapeutics \nTommy Lee is an Associate Director at Orna Therapeutics within the Discovery Team. His team focuses on the pre-clinical model developments to use panCAR for autoimmunity.
URL:https://www.biotech.ca/event/in-vivo-pancar-therapy-using-circular-rna-for-the-treatment-of-autoimmune-disease/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251106T090000
DTEND;TZID=America/Toronto:20251106T110000
DTSTAMP:20260624T081934
CREATED:20251024T205034Z
LAST-MODIFIED:20251024T205034Z
UID:10000494-1762419600-1762426800@www.biotech.ca
SUMMARY:4th Annual Life Sciences\, Society & the Law Symposium
DESCRIPTION:This year’s program will examine how the pharmaceutical and life sciences industries are responding in real time to new developments in regulation\, market dynamics\, and global trade. Through interactive discussion and diverse perspectives\, attendees will gain valuable insights on how businesses\, their advisors\, and investors are navigating change while continuing to deliver innovation and impact for Canadians. \nPanel Discussion: Reacting in Real Time: How Are the Pharmaceutical and Life Sciences Industries Adapting to Trade in 2025 – Navigating Regulatory Challenges \nModerated by Wendy Wagner\, Partner\, Gowling WLG\, this discussion will feature leading voices from across the industry — including Anne Woods (RBCx) and James Blonde (Roche Canada) — who will share insights on how organizations are adapting to uncertainty\, strengthening resilience\, and positioning for sustainable growth in a shifting market.
URL:https://www.biotech.ca/event/4th-annual-life-sciences-society-the-law-symposium/
LOCATION:First Canadian Place\, 100 King St. W\, #1600\, Toronto\, ON\, M5X 1G5\, Canada
END:VEVENT
END:VCALENDAR